Home Compare GMED vs RBA
Stock Comparison · Structural lead, mixed market

Globus Medical vs RB Global: Which Stock Looks Stronger in 2026?

Globus Medical holds the cleaner structural position, with the lead spread across growth and valuation. RB Global still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Globus Medical holds the more constructive position. That puts structure and market broadly in agreement — Globus Medical's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across growth and valuation, rather than sitting in one isolated gap. Globus Medical, Inc. leads by 27 points on the overall comparison score.

Trajectory Similarity
0.59
Moderately similar
Peer-set rank: #10
within Globus Medical, Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in margin trend and revenue growth trajectory.

Similarity drivers
margin trendrevenue growth trajectory
What reduces the match
revenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
GMED
Globus Medical, Inc.
69
Peer-Score
Signal qualityHigh
vs
RBA
RB Global, Inc.
42
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: GMED vs RBA Profitability 56 28 Stability 44 65 Valuation 81 39 Growth 95 48 GMED RBA
Gap Ranking
#1 Growth +47
#2 Valuation +42
#3 Profitability +28
#4 Stability +21
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GMED and RBA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GMEDRBA Relative valuation Structural strength

Globus Medical, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Both profiles are strong on growth, but Globus Medical, Inc. leads clearly.
Valuation
On valuation, the gap still runs the same way: Globus Medical, Inc. sits near the top of the group, while RB Global, Inc. remains in the weaker half.
Growth — Dominant Gap
GMED
95
RBA
48
Gap+47in favour of GMED

Revenue growth reinforces the category-level growth lead.

What keeps the gap from being one-sided

Stability still leans toward RB Global, Inc., so the lead is real without reading as one-way.

What this means for the comparison

The lead is built on both growth and valuation — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the GMED vs RBA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how GMED and RBA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.